Diabetes 51:1375-1382, 2002
© 2002 by the American Diabetes Association, Inc.
Detection of GAD65-Specific T-Cells by Major Histocompatibility Complex Class II Tetramers in Type 1 Diabetic Patients and At-Risk Subjects
Helena Reijonen,
Erik J. Novak,
Sharon Kochik,
Anne Heninger,
Andrew W. Liu,
William W. Kwok, and
Gerald T. Nepom
From the Virginia Mason Research Center, Benaroya Research Institute, Seattle, Washington
Soluble HLA-DR401 or -DR404 tetramers containing a peptide corresponding to an immunodominant epitope from human GAD65 were used to analyze peripheral blood T-cells of newly diagnosed type 1 diabetic patients and at-risk subjects. Peripheral blood mononuclear cells were expanded on antigen-presenting cells presenting GAD65 peptide and subsequently activated with specific plate-bound class II-peptide monomers. T-cell activation defined in flow cytometry by CD4high and/or CD25 markers were observed in all type 1 diabetic patients and some at-risk subjects, but not in normal control subjects. The activated T-cells stained positive with tetramers containing the GAD65 epitope 555-567. Tetramer-positive cells were CD4high T-cells with high avidity for an immunodominant GAD65 T-cell epitope. Phenotyping of T-cells utilizing HLA class II tetramers provides a new tool to characterize the autoimmune response in type 1 diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Monti, M. Scirpoli, A. Rigamonti, A. Mayr, A. Jaeger, R. Bonfanti, G. Chiumello, A. G. Ziegler, and E. Bonifacio
Evidence for In Vivo Primed and Expanded Autoreactive T Cells as a Specific Feature of Patients with Type 1 Diabetes
J. Immunol.,
November 1, 2007;
179(9):
5785 - 5792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. GEBE, B. FALK, K. UNRATH, and G. T. NEPOM
Autoreactive T Cells in a Partially Humanized Murine Model of T1D
Ann. N.Y. Acad. Sci.,
April 1, 2007;
1103(1):
69 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mallone, E. Martinuzzi, P. Blancou, G. Novelli, G. Afonso, M. Dolz, G. Bruno, L. Chaillous, L. Chatenoud, J.-M. Bach, et al.
CD8+ T-Cell Responses Identify {beta}-Cell Autoimmunity in Human Type 1 Diabetes
Diabetes,
March 1, 2007;
56(3):
613 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. M. Pinkse, O. H. M. Tysma, C. A. M. Bergen, M. G. D. Kester, F. Ossendorp, P. A. van Veelen, B. Keymeulen, D. Pipeleers, J. W. Drijfhout, and B. O. Roep
Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes
PNAS,
December 20, 2005;
102(51):
18425 - 18430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kinnunen, W. W. Kwok, A. Narvanen, M. Rytkonen-Nissinen, A. Immonen, S. Saarelainen, A. Taivainen, and T. Virtanen
Immunomodulatory potential of heteroclitic analogs of the dominant T-cell epitope of lipocalin allergen Bos d 2 on specific T cells
Int. Immunol.,
December 1, 2005;
17(12):
1573 - 1581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Scriba, M. Purbhoo, C. L. Day, N. Robinson, S. Fidler, J. Fox, J. N. Weber, P. Klenerman, A. K. Sewell, and R. E. Phillips
Ultrasensitive Detection and Phenotyping of CD4+ T Cells with Optimized HLA Class II Tetramer Staining
J. Immunol.,
November 15, 2005;
175(10):
6334 - 6343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mallone, S. A. Kochik, H. Reijonen, B. Carson, S. F. Ziegler, W. W. Kwok, and G. T. Nepom
Functional avidity directs T-cell fate in autoreactive CD4+ T cells
Blood,
October 15, 2005;
106(8):
2798 - 2805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Karabekian, S. D. Lytton, P. B. Silver, Y. V. Sergeev, J. P. Schneck, and R. R. Caspi
Antigen/MHC Class II/Ig Dimers for Study of Uveitogenic T Cells: IRBP p161-180 Presented by both IA and IE Molecules
Invest. Ophthalmol. Vis. Sci.,
October 1, 2005;
46(10):
3769 - 3776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. NAGATA, R. KOTANI, H. MORIYAMA, K. YOKONO, B. O. ROEP, and M. PEAKMAN
Detection of Autoreactive T Cells in Type 1 Diabetes Using Coded Autoantigens and an Immunoglobulin-Free Cytokine ELISPOT Assay: Report from the Fourth Immunology of Diabetes Society T Cell Workshop
Ann. N.Y. Acad. Sci.,
December 1, 2004;
1037(1):
10 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. I.M. TREE, B. O. ROEP, and M. PEAKMAN
Enhancing the Sensitivity of Assays to Detect T Cell Reactivity: The Effect of Cell Separation and Cryopreservation Media
Ann. N.Y. Acad. Sci.,
December 1, 2004;
1037(1):
26 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. You, C. Chen, W.-H. Lee, T. Brusko, M. Atkinson, and C.-P. Liu
Presence of Diabetes-Inhibiting, Glutamic Acid Decarboxylase-Specific, IL-10-Dependent, Regulatory T Cells in Naive Nonobese Diabetic Mice
J. Immunol.,
December 1, 2004;
173(11):
6777 - 6785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Reijonen, R. Mallone, A.-K. Heninger, E. M. Laughlin, S. A. Kochik, B. Falk, W. W. Kwok, C. Greenbaum, and G. T. Nepom
GAD65-Specific CD4+ T-Cells with High Antigen Avidity Are Prevalent in Peripheral Blood of Patients With Type 1 Diabetes
Diabetes,
August 1, 2004;
53(8):
1987 - 1994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wong, R. Lau, J. Chang, T. Kuus-Reichel, V. Brichard, C. Bruck, and J. Weber
Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma
Clin. Cancer Res.,
August 1, 2004;
10(15):
5004 - 5013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. I.M. Tree, G. Duinkerken, S. Willemen, R. R.P. de Vries, and B. O. Roep
HLA-DQ-Regulated T-Cell Responses to Islet Cell Autoantigens Insulin and GAD65
Diabetes,
July 1, 2004;
53(7):
1692 - 1699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Danke, D. M. Koelle, C. Yee, S. Beheray, and W. W. Kwok
Autoreactive T Cells in Healthy Individuals
J. Immunol.,
May 15, 2004;
172(10):
5967 - 5972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Viglietta, C. Baecher-Allan, H. L. Weiner, and D. A. Hafler
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
J. Exp. Med.,
April 5, 2004;
199(7):
971 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mallone, S. A. Kochik, E. M. Laughlin, V. H. Gersuk, H. Reijonen, W. W. Kwok, and G. T. Nepom
Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells
Diabetes,
April 1, 2004;
53(4):
971 - 977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Masteller, M. R. Warner, W. Ferlin, V. Judkowski, D. Wilson, N. Glaichenhaus, and J. A. Bluestone
Peptide-MHC Class II Dimers as Therapeutics to Modulate Antigen-Specific T Cell Responses in Autoimmune Diabetes
J. Immunol.,
November 15, 2003;
171(10):
5587 - 5595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. REIJONEN, W. W. KWOK, and G. T. NEPOM
Detection of CD4+ Autoreactive T Cells in T1D Using HLA Class II Tetramers
Ann. N.Y. Acad. Sci.,
November 1, 2003;
1005(1):
82 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. EISENBARTH
Insulin Autoimmunity: Immunogenetics/Immunopathogenesis of Type 1A Diabetes
Ann. N.Y. Acad. Sci.,
November 1, 2003;
1005(1):
109 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Panagiotopoulos, H. Qin, R. Tan, and C. B. Verchere
Identification of a {beta}-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes
Diabetes,
November 1, 2003;
52(11):
2647 - 2651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gianani and G. S. Eisenbarth
Autoimmunity to Gastrointestinal Endocrine Cells in Autoimmune Polyendocrine Syndrome Type I
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1442 - 1444.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Reddy, E. Bettelli, L. Nicholson, H. Waldner, M.-H. Jang, K. W. Wucherpfennig, and V. K. Kuchroo
Detection of Autoreactive Myelin Proteolipid Protein 139-151-Specific T Cells by Using MHC II (IAs) Tetramers
J. Immunol.,
January 15, 2003;
170(2):
870 - 877.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|